Sanofi reveals setback for cancer drug acquired in Synthorx buyout
29 Oct 2022 //
BIOPHARMADIVE
Bayer backs a George Church spinout trying to turn lab-invented amino acids
04 Nov 2021 //
ENDPTS
Sanofi drops `intriguing` data on rival to Bristol Myers` bempeg
10 Apr 2021 //
FIERE BIOTECH
Asher Bio banks $55M to deliver more selective cytokines
23 Mar 2021 //
FIERCEBIOTECH
Laura Shawver is about to join lineup ofbiotech CEOs enjoying overnight fortunes
04 Dec 2020 //
ENDPTS
Sanofi teams up with Merck to pair Keytruda with a next-gen IL-2 Synthorx buyout
29 Oct 2020 //
ENDPTS
GSK culls top respiratory disease prospect, another blow to IL-33 field
29 Oct 2020 //
FIERCE BIOTECH
Silverback names Synthorx vet Shawver as CEO—Chutes & Ladders
26 Apr 2020 //
FIERCE BIOTECH
Silverback names Synthorx vet Shawver as CEO—Chutes & Ladders
24 Apr 2020 //
FIERCE BIOTECH
Sanofi completes acquisition of immuno-oncology specialist Synthorx
24 Jan 2020 //
PMLIVE
Sanofi Reports Expiration Of HSR Waiting Period For Synthorx Deal - Quick Facts
20 Jan 2020 //
NASDAQ
Sanofi shares rally on new margin goals, narrower drug focus
11 Dec 2019 //
REUTERS
Sanofi to acquire Synthorx to bolster its immuno-oncology pipeline for $2.5 Billion
10 Dec 2019 //
BIOPHARMADIVE
Sanofi CEO hints at tomorrow`s vision reveal with cancer buy
09 Dec 2019 //
FIERCE PHARMA
Top Scripps scientist and biotech co-founder makes an abrupt & unexplained —exit
10 Aug 2019 //
ENDPTS